Your Location:Home >Products >Inhibitor >280749-17-9

Purity:99%
The present invention relates to novel c...
The interaction between leukocyte functi...
2-isopropylbenzenethiol
1-chloro-2-nitro-4-((E)-((4-acetylpiperazin-1-yl)carbonyl)ethenyl)benzene
(2-iso-propylphenyl)[2-nitro-4-(E-((4-acetylpiperazin-1-yl)carbonyl)ethenyl)phenyl]sulfide
| Conditions | Yield |
|---|---|
|
With
potassium carbonate;
In
N,N-dimethyl-formamide;
at 20 ℃;
for 1h;
|
N-acetylpiperidine
(2-iso-propylphenyl)[2-nitro-4-(E-((4-acetylpiperazin-1-yl)carbonyl)ethenyl)phenyl]sulfide
| Conditions | Yield |
|---|---|
|
Multi-step reaction with 2 steps
1: 91.6 percent / EDAC / dimethylformamide / 2 h / 20 °C
2: K2CO3 / dimethylformamide / 1 h / 20 °C
With
potassium carbonate; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride;
In
N,N-dimethyl-formamide;
1: Acylation / 2: Substitution;
|
2-isopropylbenzenethiol
1-chloro-2-nitro-4-((E)-((4-acetylpiperazin-1-yl)carbonyl)ethenyl)benzene
N-acetylpiperidine
(E)-4-chloro-3-nitrocinnamic acid
CAS:115473-15-9
CAS:1173-88-2
CAS:956121-30-5
CAS:1034297-58-9